Of 491 breast cancer patients with P/LP variants in breast cancer susceptibility genes, 72.3% (n = 355) were BRCA1 or BRCA2 variants, while 139 patients had non-BRCA variants. The gene discussed is BRCA2; the disease is breast carcinoma.